These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8327143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Restoring the DHA levels in the brains of Zellweger patients.
    Martinez M.
    J Mol Neurosci; 2001; 16(2-3):309-16; discussion 317-21. PubMed ID: 11478386
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders.
    Martínez M, Vázquez E, García-Silva MT, Manzanares J, Bertran JM, Castelló F, Mougan I.
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):376S-85S. PubMed ID: 10618001
    [Abstract] [Full Text] [Related]

  • 4. Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study.
    Martinez M, Mougan I, Roig M, Ballabriga A.
    Lipids; 1994 Apr; 29(4):273-80. PubMed ID: 8177020
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of generalized peroxisomal disorders with docosahexaenoic acid ethyl ether].
    Martínez M, Vázquez E, García-Silva MT, Beltrán JM, Castelló F, Pineda M, Mougan I.
    Rev Neurol; 1999 Jan; 28 Suppl 1():S59-64. PubMed ID: 10778491
    [Abstract] [Full Text] [Related]

  • 7. MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders.
    Martinez M, Vazquez E.
    Neurology; 1998 Jul; 51(1):26-32. PubMed ID: 9674774
    [Abstract] [Full Text] [Related]

  • 8. Visual follow-up in peroxisomal-disorder patients treated with docosahexaenoic Acid ethyl ester.
    Noguer MT, Martinez M.
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2277-85. PubMed ID: 19933185
    [Abstract] [Full Text] [Related]

  • 9. Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.
    McNamara RK, Moser AB, Jones RI, Jandacek R, Patino LR, Strawn JR, Strakowski SM, DelBello MP.
    Psychiatry Res; 2016 Dec 30; 246():803-807. PubMed ID: 27825781
    [Abstract] [Full Text] [Related]

  • 10. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG, Takahashi Y, Ide T.
    Metabolism; 2006 Mar 30; 55(3):381-90. PubMed ID: 16483883
    [Abstract] [Full Text] [Related]

  • 11. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N.
    Lipids Health Dis; 2015 Sep 02; 14():99. PubMed ID: 26328782
    [Abstract] [Full Text] [Related]

  • 12. Docosahexaenoic acid therapy in docosahexaenoic acid-deficient patients with disorders of peroxisomal biogenesis.
    Martinez M.
    Lipids; 1996 Mar 02; 31 Suppl():S145-52. PubMed ID: 8729110
    [Abstract] [Full Text] [Related]

  • 13. Docosahexaenoic acid concentrations in retinal phospholipids of piglets fed an infant formula enriched with long-chain polyunsaturated fatty acids: effects of egg phospholipids and fish oils with different ratios of eicosapentaenoic acid to docosahexaenoic acid.
    Alessandri JM, Goustard B, Guesnet P, Durand G.
    Am J Clin Nutr; 1998 Mar 02; 67(3):377-85. PubMed ID: 9497179
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S, Arora RR, Singh M, Khosla S.
    Am J Ther; 2016 Mar 02; 23(3):e905-10. PubMed ID: 25828517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.
    Martinez M.
    Brain Res; 1992 Jun 26; 583(1-2):171-82. PubMed ID: 1504825
    [Abstract] [Full Text] [Related]

  • 18. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS, Conquer JA, Thomas R.
    Reprod Nutr Dev; 2005 Jun 26; 45(5):549-58. PubMed ID: 16188207
    [Abstract] [Full Text] [Related]

  • 19. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
    Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR.
    Nutrition; 2012 Jun 26; 28(6):670-7. PubMed ID: 22541055
    [Abstract] [Full Text] [Related]

  • 20. Fatty acids in plasma, white and red blood cells, and tissues after oral or intravenous administration of fish oil in rats.
    Barros KV, Carvalho PO, Cassulino AP, Andrade I, West AL, Miles EA, Calder PC, Silveira VL.
    Clin Nutr; 2013 Dec 26; 32(6):993-8. PubMed ID: 23541913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.